Abbares Pharmaceuticals Private Limited

Abbares Pharmaceuticals Private Limited - pharma in Jodhpur, Rajasthan, India. FY 2026 financials and compliance.
CIN U51909RJ2018PTC060761 Incorporated 31 March 2018 ROC Jaipur HQ Jodhpur, Rajasthan, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹34.8 Cr
▲ 6.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹4.23 Cr
Satisfied ₹4.47 Cr
Company age
8 yrs
Est. 2018
Last financials
Mar 2025
Balance sheet date

About Abbares Pharmaceuticals Private Limited

Data last updated: 05 January 2026

Abbares Pharmaceuticals Private Limited is a private limited company based in Jodhpur, Rajasthan, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 31 March 2018, the company has been in operation for over 8 years.

Registered with ROC Jaipur under CIN U51909RJ2018PTC060761.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Rajesh Bhardwaj and Preksha Bhardwaj.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Villa No 14 Umaid Haritage Ratanada, Jodhpur, Rajasthan, India – 342011.

As per the financials filed for FY 2025, the company reported a revenue of ₹34.8 Cr, a growth of 6% compared to the previous year.

As per MCA filings, the company has open charges of ₹4.23 Cr and satisfied charges of ₹4.47 Cr on record.

For more details, the company can be reached via its website abbarespharma.com.

Company Details of Abbares Pharmaceuticals Private Limited
CIN U51909RJ2018PTC060761
Registration Number 060761
Incorporation Date 31 March 2018
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Villa No 14 Umaid Haritage Ratanada, Jodhpur, Rajasthan, India – 342011
  • Industry
    Pharma, Drug Formulation & Development
Company report
Abbares Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Abbares Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Abbares Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Abbares Pharmaceuticals Private Limited

Abbares Pharmaceuticals Private Limited is audited by Vinod Kumar Mehta for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Vinod Kumar Mehta Locked Locked Locked
Premium access

Complete auditor history for Abbares Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Abbares Pharmaceuticals Private Limited

Abbares Pharmaceuticals Private Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rajesh Bhardwaj Director 31 Mar 2018 8 Years 4 Months Current
Preksha Bhardwaj Director 15 Jun 2019 7 Years 2 Months Current
Seema Bhardwaj Director 01 Nov 2021 4 Years 9 Months Current

Financials of Abbares Pharmaceuticals Private Limited FY 2025 filings available

Abbares Pharmaceuticals Private Limited reported revenue of ₹34.8 Cr (up 6.00% YoY) for FY 2025.

Revenue · FY 2025
₹34.8 Cr ▲ 6.00%
Premium access

Ten-year financial statements for Abbares Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Abbares Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Abbares Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Abbares Pharmaceuticals Private Limited

Open charges
₹4.23 Cr
Satisfied charges
₹4.47 Cr
Breakdown by lending institutions
Others₹4.18 Cr
Hdfc Bank Limited₹0.05 Cr
Latest charge details
DateLenderAmountStatus
20 Nov 2023 Others ₹3.5 Cr Open
18 Oct 2022 Others ₹68 Lakh Open
21 Dec 2021 Hdfc Bank Limited ₹5.06 Lakh Open
30 Sep 2022 Others ₹2.97 Cr Satisfied
29 Jan 2021 Hdfc Bank Limited ₹1.2 Cr Satisfied

Total charge records: 10 View all charges

Employees and EPFO Compliance at Abbares Pharmaceuticals Private Limited

View historical data on people associated with Abbares Pharmaceuticals Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Abbares Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Abbares Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Abbares Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Abbares Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Abbares Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Abbares Pharmaceuticals Private Limited

Premium access

MSME payment history for Abbares Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Abbares Pharmaceuticals Private Limited

Premium access

Corporate group structure for Abbares Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Abbares Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Abbares Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Abbares Pharmaceuticals Private Limited

Activity
30 Sep 2025
Abbares Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Abbares Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
15 Mar 2024
A charge registered on 23 Jan 2019 via Charge ID 100239394 with Others was fully satisfied on 15 Mar 2024.
Charges
01 Mar 2024
A charge with Others of Rs. 350.00 Lakh registered on 20 Nov 2023 with Charge ID 100844174 was modified on 01 Mar 2024.
Charges
27 Feb 2024
A charge registered on 30 Sep 2022 via Charge ID 100618580 with Others was fully satisfied on 27 Feb 2024.
Charges
02 Feb 2024
A charge registered on 29 Jan 2021 via Charge ID 100420556 with Hdfc Bank Limited was fully satisfied on 02 Feb 2024.

Frequently Asked Questions about Abbares Pharmaceuticals Private Limited

Abbares Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Jodhpur, Rajasthan, India. It was incorporated on 31 March 2018 (8+ years old) and is registered under CIN U51909RJ2018PTC060761.

Abbares Pharmaceuticals Private Limited reported revenue of ₹34.8 Cr for FY 2025 (up 6.00% YoY).

The current directors of Abbares Pharmaceuticals Private Limited are:

The primary industry of Abbares Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Abbares Pharmaceuticals Private Limited can be reached at the registered office: Villa No 14 Umaid Haritage Ratanada, Jodhpur, Rajasthan, India – 342011, or through the website abbarespharma.com.

The authorised capital is ₹10 Lakh, and the paid-up capital is ₹10 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available